The elevated levels of serum resistin, TNF-α, IL-6, and hepatic enzymes suggest that resistin may contribute to NAFLD, at least in part, through upregulating systemic and hepatic inflammation. Here, IL6 is linked to metabolic dysfunction-associated steatotic liver disease.